Tessa Therapeutics Competitors and Similar CompaniesClear all

Cryo-Cell's competitors and similar companies include Vericel.
Cryo-Cell
Cryo-Cell
Cryo-Cell International is a provider of cord blood banking and cord tissue storage services.
Vericel
Vericel
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.
Founding Date
Founding Date
1989
Founding Date
1989
Type
Type
Public
Type
Public
Tags
Locations
Locations
Oldsmar, US HQ
Santiago, CL
San Pedro Sula, HN
Guadalajara, MX
Panamá City, PA
North Miami Beach, US
Caracas, VE
Locations
Cambridge, US HQ
Ann Arbor, US
Employees
Employees
804% decrease
Employees
24112% increase
Valuation ($)
Valuation ($)
47.9 m
Valuation ($)
2.2 b

Financial

Revenue (est.)
Revenue (est.)
$31.6m (FY, 2025)
Revenue (est.)
$276.3m (FY, 2025)
Cost of goods
Cost of goods
$7.4m (FY, 2025)
Cost of goods
$70.7m (FY, 2025)
Gross profit
Gross profit
$24.2m (FY, 2025)
Gross profit
$205.6m (FY, 2025)
Net income
Net income
($2.4m) (FY, 2025)
Net income
$16.5m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Vericel
HQ
Cambridge, US
Employees
241↑ 12% increase

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.

View company